Papuamine Inhibits Viability of Non-small Cell Lung Cancer Cells by Inducing Mitochondrial Dysfunction

Hye-Young Min1, Yujin Jung2, Kwan Hee Park3

  • 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, Republic of Korea.

Anticancer Research
|January 2, 2020
PubMed
Abstract

Insights

Papuamine, a natural product, effectively targets cancer cell mitochondria, inhibiting their viability and ATP production. This compound shows promise as a novel anticancer agent by inducing apoptosis in non-small cell lung cancer cells.

Area of Science:

  • Mitochondrial biology
  • Cancer research
  • Natural product chemistry

Background:

  • Mitochondria are crucial for cancer cell survival, even with the Warburg effect.
  • Mitochondria represent a viable target for developing novel anticancer agents.

Purpose of the Study:

  • Identify a mitochondria-targeting anticancer agent from natural products.
  • Evaluate the efficacy of papuamine against non-small cell lung cancer (NSCLC).

Main Methods:

  • High Content Imaging System for mitochondrial analysis.
  • Cell viability, colony formation, cell cycle, and immunoblotting assays.
  • Utilized NSCLC cell lines (H1299, H226B, A549).

Main Results:

  • Papuamine inhibited NSCLC cell viability and ATP production.
  • Papuamine induced mitochondrial dysfunction, including loss of membrane potential and increased superoxide generation.
  • Papuamine significantly inhibited colony formation and induced apoptosis in NSCLC cells.

Conclusions:

  • Papuamine demonstrates potential as a novel anticancer agent.
  • Papuamine's mechanism involves targeting cancer cell mitochondria.